BOEHRINGER INGELHEIM PHARMA, GmbH & Co.KG ,   Germany

Antiaggregant agent
Capsules with modified release.
Fibrinolytic agent - plasminogen activator

Liofilizate for the preparation of a solution for infusions complete with a solvent.

Bronchodilator combined (beta2-adrenomimetic selective + m-holinoblokator)

Aerosol for inhalation dosed, 20 mcg + 50 mcg / dose.

Bronchodilator - beta2-adrenomimetic selective

Aerosol for inhalation dosed, 0.1 mg / dose.

Antitumor agent - protein tyrosine kinase inhibitor
Capsules 100, 150 mg.
Hypoglycemic agent for oral administration combined

Tablets, film-coated, 5 mg 10 mg + 5 mg + 25 mg.

Hypoglycemic agent for oral administration

Tablets, film-coated, 10 mg and 25 mg.

A hypoglycemic agent for oral administration combined (dipeptidyl peptidase-4-inhibitor + biguanide)
Tablets, film-coated, 2.5 mg + 500 mg / 2.5 mg + 850 mg / 2.5 mg + 1000 mg.
antihypertensive drug combined (apogotenzin II receptor antagonist + diuretic).
Tablets 12.5 / 40 mg and 12.5 / 80 mg.
A combined hypotensive drug (angiotensin II receptor antagonist + diuretic)
Tablets 25/80 mg.
Non-steroidal anti-inflammatory drug - NSAIDs
Tablets 7.5 mg or 15.0 mg.
Thrombin inhibitor direct

Capsules, 75 mg, 110 mg and 150 mg.

Direct thrombin inhibitor
Capsules 150 mg.

antibodies monoclonal
M-holinoblokator
Solution for inhalation 2.5 μg / dose
bronchodilator - beta2-adrenergic selective

Solution for inhalation, 2.5 μg / dose.

antihypertensive agent combined (blocker of "slow" calcium channels + angiotensin II receptor antagonist)

Tablets 5 mg + 40 mg, 10 mg + 40 mg, 5 mg + 80 mg, 10 mg + 80 mg.

Local irritant
Cream for external use.
immunosuppressive agent
Lyophilizate for the preparation of a solution for subcutaneous administration, 10 mg.
Tumor necrosis factor-alpha (TNF-alpha) inhibitors

Lyophilizate for the preparation of a solution for subcutaneous administration, 25 mg.